Breast cancer remains a significant global health challenge, with prognosis and treatment decisions largely dependent on clinical characteristics. Accurate prediction of patient outcomes is crucial for personalized treatment strategies. This study employs survival analysis techniques, including Cox proportional hazards and parametric survival models, to enhance the prediction of the log odds of survival in breast cancer patients. Clinical variables such as tumor size, hormone receptor status, HER2 status, age, and treatment history were analyzed to assess their impact on survival outcomes. Data from 1557 breast cancer patients were obtained from a publicly available dataset provided by the University College Hospital, Ibadan, Nigeria. This dataset was preprocessed and analyzed using both univariate and multivariate approaches to evaluate survival outcomes. Kaplan-Meier survival curves were generated to visualize survival probabilities, while the Cox proportional hazards model identified key risk factors influencing mortality. The results showed that older age, larger tumor size, and HER2-positive status were significantly associated with an increased risk of mortality. In contrast, estrogen receptor positivity and breast-conserving surgery were linked to better survival outcomes. The findings suggest that integrating these clinical variables into predictive models improves the accuracy of survival predictions, helping to identify high-risk patients who may benefit from more aggressive interventions. This study demonstrates the potential of survival analysis in
optimizing breast cancer care, particularly in resource-limited settings.
Future research should focus on integrating genomic data and real-world
clinical outcomes to further refine these models.
Cite this paper
Alamu, O. S. , Choque, B. J. G. , Rizvi, S. W. A. , Hammed, S. B. , Medani, I. E. , Siam, M. K. and Tahir, W. A. (2024). Predicting Breast Cancer Survival: A Survival Analysis Approach Using Log Odds and Clinical Variables. Open Access Library Journal, 11, e2317. doi: http://dx.doi.org/10.4236/oalib.1112317.
Efficace, F., Collins, G.S., Cottone, F., Giesinger, J.M., Sommer, K., Anota, A., et al. (2021) Patient-Reported Outcomes as In-dependent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-analysis. Value in Health, 24, 250-267. https://doi.org/10.1016/j.jval.2020.10.017
Luo, C., Li, N., Lu, B., Cai, J., Lu, M., Zhang, Y., et al. (2021) Global and Regional Trends in Incidence and Mortality of Female Breast Cancer and Associated Factors at National Level in 2000 to 2019. Chinese Medical Journal, 135, 42-51. https://doi.org/10.1097/cm9.0000000000001814
Hosmer, D.W., Lemeshow, S. and May, S. (2008) Applied Survival Analysis: Regression Modeling of Time-to-Event Data (vol. 618). Wiley. https://doi.org/10.1002/9780470258019
Aberaraw, R., Boka, A., Teshome, R. and Yeshambel, A. (2020) Social Networks and Quality of Life among Female Breast Cancer Patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia 2019. BMC Women’s Health, 20, Article No. 50. https://doi.org/10.1186/s12905-020-00908-8
Daniele, A., Divella, R., Pilato, B., Tommasi, S., Pasanisi, P., Patruno, M., et al. (2021) Can Harmful Lifestyle, Obesity and Weight Changes Increase the Risk of Breast Cancer in BRCA 1 and BRCA 2 Mutation Carriers? A Mini Review. Hereditary Cancer in Clinical Practice, 19, Article No. 45. https://doi.org/10.1186/s13053-021-00199-6
Ahmad, A. (2019) Breast Cancer Statis-tics: Recent Trends. In: Ahmad, A., Ed., Breast Cancer Metastasis and Drug Resistance, Springer, 1-7. https://doi.org/10.1007/978-3-030-20301-6_1
Ajmera, P., Yadav, P., Dosi, U. and Goyal, S. (2022) Analysing the Insights and Assessing the Impact of a Digital Mammography and Tomosynthesis Based 2-Year Long Prospective Breast Screening Programme Organised in Western India. Asian Pacific Journal of Cancer Prevention, 23, 327-338. https://doi.org/10.31557/apjcp.2022.23.1.327
DeSantis, C.E., Ma, J., Gaudet, M.M., Newman, L.A., Miller, K.D., Goding Sauer, A., et al. (2019) Breast Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 438-451. https://doi.org/10.3322/caac.21583
Dyba, T., Randi, G., Bray, F., Martos, C., Giusti, F., Nicholson, N., et al. (2021) The European Cancer Burden in 2020: Incidence and Mortality Estimates for 40 Countries and 25 Major Cancers. European Journal of Cancer, 157, 308-347. https://doi.org/10.1016/j.ejca.2021.07.039
Emmert-Streib, F. and Dehmer, M. (2019) Introduction to Survival Analysis in Practice. Machine Learning and Knowledge Extraction, 1, 1013-1038. https://doi.org/10.3390/make1030058
Gobeyn, S., Mouton, A.M., Cord, A.F., Kaim, A., Volk, M. and Goethals, P.L.M. (2019) Evolutionary Algorithms for Species Distribution Modelling: A Review in the Context of Machine Learning. Ecological Modelling, 392, 179-195. https://doi.org/10.1016/j.ecolmodel.2018.11.013
Hiatt, R.A., Engmann, N.J., Balke, K. and Rehkopf, D.H. (2020) A Complex Systems Model of Breast Cancer Etiology: The Paradigm II Conceptual Model. Cancer Epi-demiology, Biomarkers & Prevention, 29, 1720-1730. https://doi.org/10.1158/1055-9965.epi-20-0016
Li, Y., Yang, D., Yin, X., Zhang, X., Huang, J., Wu, Y., et al. (2020) Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients with Single Hormone Receptor-Positive Breast Cancer. JAMA Network Open, 3, e1918160. https://doi.org/10.1001/jamanetworkopen.2019.18160
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R. and Stanisławek, A. (2021) Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review. Cancers, 13, Article 4287. https://doi.org/10.3390/cancers13174287
Muddather, H.F., Faggad, A. and Elhassan, M.M.A. (2022) Relapse-Free Survival in Sudanese Women with Non-Metastatic Breast Cancer. Global Epidemiology, 4, Article ID: 100082. https://doi.org/10.1016/j.gloepi.2022.100082
Nezhad, M.Z., Sadati, N., Yang, K. and Zhu, D. (2019) A Deep Active Survival Analysis Approach for Precision Treatment Recommendations: Application of Prostate Cancer. Expert Systems with Applications, 115, 16-26. https://doi.org/10.1016/j.eswa.2018.07.070
Nielsen, A.B., Thorsen-Meyer, H., Belling, K., Nielsen, A.P., Thomas, C.E., Chmura, P.J., et al. (2019) Survival Prediction in Intensive-Care Units Based on Aggregation of Long-Term Disease History and Acute Physiology: A Retrospective Study of the Danish National Patient Registry and Elec-tronic Patient Records. The Lancet Digital Health, 1, e78-e89. https://doi.org/10.1016/s2589-7500(19)30024-x
Oqal, M., Odeh, M., Abudalu, R., Alqudah, A., Alnajjar, R., Younes, Y.B., et al. (2022) Assessing the Knowledge, Attitudes and Barriers Regarding Health Promotion of Breast Cancer among Community Pharmacists. Future Science OA, 8, FSO826. https://doi.org/10.2144/fsoa-2022-0051
Pickett, K.L., Suresh, K., Campbell, K.R., Davis, S. and Juarez-Colunga, E. (2021) Random Survival Forests for Dynamic Predictions of a Time-To-Event Outcome Using a Longitudinal Biomarker. BMC Medical Research Methodology, 21, Article No. 216. https://doi.org/10.1186/s12874-021-01375-x
Ramsey, I., de Rooij, B.H., Mols, F., Corsini, N., Horevoorts, N.J.E., Eck-ert, M., et al. (2019) Cancer Survivors Who Fully Participate in the PROFILES Registry Have Better Health-Related Quality of Life than Those Who Drop Out. Journal of Cancer Survivorship, 13, 829-839. https://doi.org/10.1007/s11764-019-00793-7
Rosskamp, M., Verbeeck, J., Gadeyne, S., Verdoodt, F. and De Schut-ter, H. (2021) Socio-economic Position, Cancer Incidence and Stage at Diagnosis: A Nationwide Cohort Study in Belgium. Cancers, 13, Article 933. https://doi.org/10.3390/cancers13050933
Tsimberidou, A.M., Fountzilas, E., Nikanjam, M. and Kurzrock, R. (2020) Review of Precision Cancer Medicine: Evolution of the Treatment Paradigm. Cancer Treatment Reviews, 86, Article ID: 102019. https://doi.org/10.1016/j.ctrv.2020.102019
Ward, E.M., Sherman, R.L., Henley, S.J., Jemal, A., Siegel, D.A., Feuer, E.J., et al. (2019) Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20=49 Years. JNCI: Journal of the National Cancer Institute, 111, 1279-1297. https://doi.org/10.1093/jnci/djz106
Testa, U., Castelli, G. and Pelosi, E. (2020) Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments. Medical Sciences, 8, Article 18. https://doi.org/10.3390/medsci8010018
Tran, K.A., Kondrashova, O., Bradley, A., Williams, E.D., Pearson, J.V. and Waddell, N. (2021) Deep Learning in Cancer Diagnosis, Prognosis and Treatment Selection. Genome Medicine, 13, Article No. 152. https://doi.org/10.1186/s13073-021-00968-x